CORD-19:a44cd4fe9a7c450cf0e3e0fe955d43f824bb3ebe / 33845-34047
Annnotations
CORD-19-Sentences
{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T196","span":{"begin":0,"end":202},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Indeed, antagonists to CCR1 can treat ongoing EAE (Liang et al, 2000) by presumably interfering with the ability of CCL3 and/or CCL5 from inducing accumulation of T cells in the CNS (Fife et al, 2001) ."}
CORD-19_Custom_license_subset
{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T196","span":{"begin":0,"end":202},"obj":"Sentence"}],"text":"Indeed, antagonists to CCR1 can treat ongoing EAE (Liang et al, 2000) by presumably interfering with the ability of CCL3 and/or CCL5 from inducing accumulation of T cells in the CNS (Fife et al, 2001) ."}
CORD-19-PD-UBERON
{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T164","span":{"begin":178,"end":181},"obj":"Body_part"}],"attributes":[{"id":"A164","pred":"uberon_id","subj":"T164","obj":"http://purl.obolibrary.org/obo/UBERON_0001017"}],"text":"Indeed, antagonists to CCR1 can treat ongoing EAE (Liang et al, 2000) by presumably interfering with the ability of CCL3 and/or CCL5 from inducing accumulation of T cells in the CNS (Fife et al, 2001) ."}
CORD-19-PD-MONDO
{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T97","span":{"begin":46,"end":49},"obj":"Disease"},{"id":"T47556","span":{"begin":46,"end":49},"obj":"Disease"}],"attributes":[{"id":"A97","pred":"mondo_id","subj":"T97","obj":"http://purl.obolibrary.org/obo/MONDO_0005134"},{"id":"A68301","pred":"mondo_id","subj":"T47556","obj":"http://purl.obolibrary.org/obo/MONDO_0005134"}],"text":"Indeed, antagonists to CCR1 can treat ongoing EAE (Liang et al, 2000) by presumably interfering with the ability of CCL3 and/or CCL5 from inducing accumulation of T cells in the CNS (Fife et al, 2001) ."}